Phase II study of a human anti-interleukin (IL)-12/IL-23 monoclonal antibody in the treatment of psoriasis

被引：0
|
作者：
Langely, RG
Lebwohl, M
Leonardi, C
Yeilding, N
Guzzo, C
Wang, Y
Dooley, L
Krueger, GG
机构：
[1] Dalhousie Univ, Halifax, NS B3H 3J5, Canada
[2] Mt Sinai Sch Med, New York, NY USA
[3] St Louis Univ, St Louis, MO 63103 USA
[4] Centocor Inc, Malvern, PA 19355 USA
[5] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2005年 / 125卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
407
引用
收藏
页码：A69 / A69
页数：1
相关论文
共 50 条
  • [31] Interleukin (IL)-12 and IL-23 are key cytokines for immunity against salmonella in humans
    MacLennan, C
    Fieschi, C
    Lammas, DA
    Picard, C
    Dorman, SE
    Sanal, O
    MacLennan, JM
    Holland, SM
    Ottenhoff, THM
    Casanova, JL
    Kumararatne, DS
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (10): : 1755 - 1757
  • [32] IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants
    de Paus, Roelof A.
    van de Wetering, Diederik
    van Dissel, Jaap T.
    van de Vosse, Esther
    MOLECULAR IMMUNOLOGY, 2008, 45 (15) : 3889 - 3895
  • [33] Interleukin-12/23 monoclonal antibody for psoriasis - Reply
    Krueger, Gerald G.
    Langley, Richard G.
    Yeilding, Newman
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19): : 2003 - 2003
  • [34] Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis
    Alunno, Alessia
    Carubbi, Francesco
    Cafaro, Giacomo
    Pucci, Giacomo
    Battista, Francesca
    Bartoloni, Elena
    Giacomelli, Roberto
    Schillaci, Giuseppe
    Gerli, Roberto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1727 - 1737
  • [35] Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
    Fuss, IJ
    Becker, C
    Yang, ZQ
    Groden, C
    Hornung, RL
    Heller, F
    Neurath, MF
    Strober, W
    Mannon, PJ
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) : 9 - 15
  • [36] Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
    Borg, Emma
    Thoning, Henrik
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (06) : 901 - 902
  • [37] Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
    Yang, Eric J.
    Smith, Mary Patricia
    Ly, Karen
    Bhutani, Tina
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1993 - 2000
  • [38] Modulation of apoptosis in human melanoma cell lines by anti-interleukin (IL)-6, anti-IL-15, and taxol treatment
    Lanza, L
    Scudeletti, M
    Meazza, R
    Ferrini, S
    Monetti, M
    Monaco, E
    Indiveri, F
    Jasmin, C
    Azzarone, B
    CANCER GENE THERAPY, 1998, 5 (06) : S30 - S31
  • [39] Mondor Disease in a Patient With Psoriasis Treated With an Anti-Interleukin 12/Interleukin 23 Investigational Drug
    Hirano, Stefanie A.
    Mason, Ashley R.
    Warthan, Molly M.
    Pariser, Robert J.
    ARCHIVES OF DERMATOLOGY, 2010, 146 (09) : 1049 - 1050
  • [40] The psoriasis associated IL12B risk haplotype influences IL-12 and IL-23 expression and secretion
    Gudjonsson, J. E.
    Xing, X.
    Nair, R. P.
    Voorhees, J. I.
    Johnston, A.
    Elder, J. T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S20 - S20
12345